US – Despite the volatility of last year’s economy due to the corona virus pandemic, diabetes technology companies experienced tremendous success. Analysts have been bullish on the market as companies target new patient populations and major product launches have been planned for 2021 with clinicians approving of the same. Recent surveys of healthcare professionals projecting both the use of continuous glucose monitors and insulin pumps to jump in the coming years. While continuous glucose monitoring (CGMs) and insulin pumps are the primary devices in diabetes tech, the space is also…
Read MoreDiabetes tech market continues to witness an upward trend as more companies are coming up with new innovations
